Hospital@Home: Telemedical Care After Inpatient Hospital Stay

NCT05617560 | Completed

• 1 other identifier: 2022-01440; am22Eckstein2
• Study Type: interventional
• Target: 234
• Locations: 1 country
• Sites: 1

Brief Summary

This pilot study is to investigate a patient transfer path from the hospital to Hospital@Home to their general practitioners (GPs) using telemedical procedures. Telemedical support will be executed by Medgate who will refer the patients to their GPs after the telemedical consultations are completed. Inclusion criteria is the need for short time follow up procedures that can be handled by telemedicine. Throughout the study, patient and stakeholder satisfaction will be measured and data-based methods will be developed to assess patient transfer success. Overall, new information flow and communication between the stakeholders (hospital, telemedicine and general practitioners) are defined and tested. The Hospital@Home pilot study is intended to become a flagship project for new healthcare models.

Conditions

Telemedicine

Keywords

Medgate; Patient transfer path; Telemedical care; Telephone consultation; Videocall consultation; ergebnisorientiertes Patientenassessment - AcuteCare (ePA-AC); Patient-Reported Experience Measures Survey (PREMS); Patient Reported Outcome Measures Survey (PROMS)

Outcome Measures

Primary Outcomes (3)

• Change in PROMS (patient-reported outcome measures survey)

  PROMS (patient-reported outcome measures survey): measure to asses a patient's quality of life affected by state of health. 6 standardized questions for self-assessment of the patient's state of health by the patient. The content of the questions relates to mobility, self-care, general activities, pain, anxiety and health in general. Questions are answered using Likert scales and qualitative free text answers. Scoring: 5 multiple choice questions (example pain: no pain, mild -, moderate -, severe -, extreme pain); (example general health: Scale from 0 - 100 (0 = worst health, 100 = best health imaginable)).

  From Visit 2 (Transfer) up to Visit 4 (Follow up), approx. 2 weeks

• PREMS (patient reported experience measure survey) conducted by patients

  PREMS (patient reported experience measure survey): satisfaction related questionnaire. Questions are answered using Likert scales (Format: 1: You completely disagree with this statement. 2: - not to. 3: - rather not to. 4: - neither accept nor reject them. 5: - a little too. 6: - majority to 7: You very much agree with this statement)

  From Visit 2 (Transfer) up to Visit 4 (Follow up), approx. 2 weeks

• PREMS (patient reported experience measure survey) conducted by physicians

  PREMS (patient reported experience measure survey): satisfaction related questionnaire. Questions are answered using Likert scales (Format: 1: You completely disagree with this statement. 2: - not to. 3: - rather not to. 4: - neither accept nor reject them. 5: - a little too. 6: - majority to 7: You very much agree with this statement)

  From Visit 2 (Transfer) up to Visit 4 (Follow up), approx. 2 weeks

Other Outcomes (2)

• Change in self-care index (Selbstpflegeindex (SPI))

  From Visit 1 (Screening) up to Visit 3 (Telecare), approx. 1 week

• Change in result-oriented patient assessment (ergebnisorientiertes Patientenassessment - AcuteCare (ePA-AC))

  From Visit 1 (Screening) up to Visit 2 (Transfer) assessed daily at the hospital, approx. 1 week

Study Arms (1)

Telemedical care

EXPERIMENTAL

Other: Telemedical care

Interventions

Telemedical care OTHER

Telemedical care will be provided to all participants after stationary hospital stay. This care will be in form of telephone consultations and / or videocall consultations with a medical physician. Depending on the individual medical history and the planned aftercare and procedure of the participants it will comprise of one or more such telephone consultations.

Telemedical care

Eligibility Criteria

• Age: 18 Years+
• Sex: all
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Written informed consent as documented by signature from the patient
• Planned hospital discharge
• Intended follow-up care, that is manageable with telemedicine

You may not qualify if:

• Significant mental or cognitive impairment
• Unable or not willing to sign informed consent
• Unable to understand German
• No possibility of telecommunication or use of such (app or phone)

Sponsors & Collaborators

• University Hospital, Basel, Switzerland: lead
• Innosuisse - Swiss Innovation Agency: collaborator

Study Sites (1)

University Hospital Basel, Division of Internal Medicine

Basel, 4031, Switzerland

Location

Study Officials

• Jens Eckstein, Prof. Dr. med.

  University Hospital Basel, Division of Internal Medicine

  PRINCIPAL INVESTIGATOR

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NA
• Masking: NONE
• Purpose: HEALTH SERVICES RESEARCH
• Intervention Model: SINGLE GROUP
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Model Details: investigator-initiated, prospective, single-center clinical intervention study

Study Record Dates

• First Submitted: November 7, 2022
• First Posted: November 15, 2022
• Study Start: October 26, 2022
• Primary Completion: December 31, 2024
• Study Completion: December 31, 2024
• Last Updated: April 11, 2025

Record last verified: 2025-04

Locations

CH (1)